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Atlantoaxial vertical subluxation (VS) is one of the com-
mon instabilities and the most fatal complication for 
patients with rheumatoid arthritis (RA). Several cross-
sectional studies revealed that the incidence of VS rang-
es from 4 to 35%.1, 2 Since patients with atlantoaxial in-
stabilities are not always symptomatic, the real incidence 
of VS may actually be higher. VS may be caused by 
rheumatoid synovitis at the upper cervical spine (UCS), 
following the joint destruction of atlanto-occipital joint 
(AOJ) and atlantoaxial joint (AAJ).3–7 However, there 
have been few reports on the development of lateral 
mass collapse in the UCS with progression of VS.8, 9 
Symptoms include headache, myelopathy, dyspnea and 
sometimes death. Therefore, to detect subclinical VS 
patients and to prevent the VS progression, it is impor-
tant to reveal the morphological changes at the UCS and 
prognostic factors for VS progression.
 Many prognostic factors for VS have been reported 
previously, including age, sex, menopausal status, dura-
tion of RA symptoms, severity of RA, number of erosive 
peripheral joints, a subset with mutilating disease, and 
use of glucocorticoids.10–16 Some of the reported prog-
nostic factors for VS are also risk factors for osteoporo-
sis (OP). RA, itself, is one of the causes for secondary 
OP. Moreover, it has been reported that lumbar vertebral 
deformity in RA patients had an association with areal 
bone mineral density (BMD).17, 18 Therefore, we hypoth-
esize that OP could affect the progression of VS. This 
study had 2 aims: to identify the morphological changes 
in VS progression, and to evaluate the relationship be-
tween the progression of VS and OP. 
  
SUBJECTS AND METHODS
Subjects
Subjects were recruited from outpatient clinics at 
Tottori University Hospital between April 2008 and 
March 2009. Female patients were eligible if they had 
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a definitive diagnosis of RA, met the revised criteria of 
the American College of Rheumatology,19 and had the 
ability to understand and complete a written informed 
consent form. Patients with postmenopausal OP were 
recruited as controls. Patients were defined as having OP 
if they: i) were over 45 years of age, ii) had no history of 
symptoms or medication use that can induce OP (includ-
ing glucocorticoids) and iii) had BMD below 70% or a 
T-score of −2.6 below the young adult mean as measured 
by a Hologic QDR bone densitometer (Hologic, Bed-
ford, MA) or osteopenia (BMD below 80% or T-score of 
−1.7 below the young adult mean) with at least 1 fragil-
ity fracture, as defined by the criteria of the Japanese 
Society for Bone and Mineral Research. A total of 111 
patients (86 patients with RA and 25 with OP) fulfilled 
these inclusion criteria. Investigators provided written 
and verbal explanations of the study and obtained a writ-
ten informed consent from each subject. 
 To investigate the etiology of VS, RA patients were 
divided into 2 groups, those with VS (VS group) and 
those without VS (non-VS group). VS was diagnosed 
when the Redlund-Johnell (R-J) value was less than 29 
mm on plain lateral radiographs.20  
  
Morphological analysis by using reconstructed CT 
images
The morphological parameters of the UCS were evalu-
ated on coronal reconstructed computed tomography 
(CT) images (Aquilion 64; Toshiba Medical Systems, 
Otawara, Japan). During CT scanning, subjects were in 
a supine position with their necks in an extended posi-
tion using a special pillow. Bone mineral reference phan-
toms, made of hydroxylapatite (Kyoto Kagaku, Kyoto, 
Japan), were placed on the neck to quantify volumetric 
BMD (vBMD) at the UCS. In patients with dentures and 
implants around the occipitocervical junction, several 
artifacts (including halation) affected the CT data. To 
avoid the influence of artifacts, the CT gantry was tilted 
30˚ caudally. After locating the region from the basioc-
ciput to C3 on a lateral scout-view of the UCS, these lev-
els were encompassed with 0.5 mm slices at 120 kV/200 
mA, with a 0.5-s/rot pitch and a 153.8-mm diameter 
field of view. 
 The coronal CT images were reconstructed with 
the axis parallel to the odontoid process. Using coronal 
reconstructed CT views, AOJ and AAJ were morpho-
logically evaluated. The anatomical parameters included 
the odontoid height, lateral mass height (LMH) of the 
atlas and axis [LMH(C1) and LMH(C2), respectively], 
and the facet angle (FA) of the atlas and axis [FA(C1) 
and FA(C2), respectively] (Fig. 1). We defined these 
parameters as follows: LMH(C1) was the perpendicular 
distance from the upper to the lower peak of the C1 lat-
eral mass. LMH(C2) was defined as the length between 
the lower endplate to the upper surface of the C2 facet. 
FA(C1) was the angle between the upper and lower facet 
surfaces, and FA(C2) was the angle between the lower 
endplate of the axis and upper facet surface of the axis. 
Odontoid height was defined as the perpendicular dis-
tance from the tip of the odontoid process to the lower 
endplate of the axis. Morphological changes at the AOJ 
and AAJ on the coronal reconstructed CT images were 
classified into 3 types: normal, erosive and ankylosing.21 
Bone defects in the odontoid process were classified into 
3 types: spot, small and large.22  
 
BMD measurements at the lumbar spine and hip
The measurements of BMD at the lumbar spine (L2-
4) [BMD(lumbar)] and right hip were performed using 
postero-anterior dual X-ray energy absorptiometry with 
the QDR Discovery instrument (Hologic). For the BMD 
of the hip [BMD(hip)], we used the neck BMD value. 
 
vBMD measurements at the UCS
To measure vBMD at the UCS, we employed the 3-di-
mensional TEIJIN Bone Structure Analysis System (3D-
TBSAS; Teijin Pharma, Tokyo, Japan), which was based 
on the theory of Azuma et al.23 
 The original raw CT data in DICOM format was ob-
tained from the same CT device (described above) with 
a slice thickness of 0.5 mm and pixel width of 0.35 mm 
and used by 3D-TBSAS to construct a 3-dimensional 
model. The system could distinguish and separate each 
Fig. 1. Anatomical parameters are defined as follows: 
 1: odontoid height (OH) 
 2: lateral mass height of the atlas, LMH(C1) 
 3: lateral mass height of the axis, LMH(C2) 
 4: facet angle of the atlas, FA(C1) 
 5: facet angle of the axis, FA(C2)
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structure according to bone continuity. The watershed 
of discontinuity was set at 0.5 mm. For each structure, 
3D-TBSAS calculated the whole tissue volume, bone 
volume, the percentage of bone tissue (bone volume/ 
tissue volume) and the average CT value for the whole 
tissue. We analyzed each phantom (200, 300, 400, 500, 
600 mg/mL, made with hydroxylapatite and 1,550 mg/
mL phantom, made with alumina) and the structures 
in the UCS. Once each structure was distinguished, 
we could unite the separate bones and calculate the 
combined vBMD using this system. Since a linear cor-
relation between vBMD and averaged CT values of the 
phantom was confirmed, the average CT value of each 
skeletal structure was calculated. Finally, the vBMD was 
calculated as follows: vBMD = average CT value × (bone 
volume/tissue volume).
 
 The percentage of coefficient of variation in this 
system was evaluated by 105 repeated measurements 
for the phantoms (300, 400, 500 and 600 mg/mL). The 
percentage of coefficient of variation was defined as less 
than 0.1%.
 Using 3D-TBSAS, we could calculate the volume 
of the atlas, axis and C1-2 [V(C1), V(C2) and V(C1-2), 
respectively], and the vBMD of the atlas, axis and C1-2 
[vBMD(C1), vBMD(C2) and vBMD(C1-2), respectively]. 
In cases of severely destructed or fused bony structures, 
3D-TBSAS could neither distinguish each structure nor 
calculate the correct vBMDs. RA patients with severe 
rheumatoid changes at the UCS were unable to calculate 
vBMDs at the UCS. The remaining 33 patients with 
RA in the non-VS group and 18 with OP were analyzed 
3-dimentionally.
 
Statistical analysis
Differences in demographic data and characteristics be-
tween 2 groups were analyzed using the Mann-Whitney 
U test, and those for 3 groups were analyzed using the 
Kruskal-Wallis test and the Steel-Dwass test for multiple 
comparisons. Pearson’s chi-square test or Fisher’s exact 
test were used to compare the categories or ratios of 
variables. Spearman’s rank correlation coefficient was 
used for the analysis between 2 parameters. P < 0.05 
was considered to indicate statistical significance. 
 To clarify the effects of OP, we performed multiple 
logistic regression analysis for the development of VS 
by using the statistical significant factors from the com-
parison between the VS and non-VS groups. Statistical 
analyses were performed using PASW Statistics version 
18.0.0 (SPSS, Chicago, IL). 
 The present study was approved by the Ethics Com-
mittee of Tottori University (No. 1088). 
  
 
Table 1. Characteristics of study patients
 OP group Non-VS group VS group P value
Number Total 19  70  10  –
 Postmenopausal 19  68  10  –
Age (yr)  72.6 (59–84) 63.3 (34–87) 69.9 (60–82) < 0.001
Body mass index (kg/m2)  22.0 (16.9–29.8) 22.2 (13.7–33.8) 21.5 (17.3–27.4) NS
BMD (g/cm2) Lumbar 0.692 (0.450–0.867) 0.879 (0.614–1.224) 0.768 (0.542–1.083)    0.002
 Femoral neck 0.646 (0.486–0.841) 0.670 (0.406–0.911) 0.590 (0.245–0.788) NS
Ranawat classification classification
 0 19  70  8  NS
 1 0  0  1
 2a 0  0  1
RA symptom duration (mo)  –  72.4 (12–456) 91.7 (11–384) < 0.001
Glucocorticoid usage: n [%]  –  38.8 [54.3] 7.0 [70] NS
CRP (mg/dL)  –  0.66 (0.04–4.41) 1.10 (0.05–4.95) NS
ESR (mm/h)  –  43.9 (8–117) 47.6 (12–99) NS
RF (IU/mL)  –  140.8 (5.0–980.1) 115.4 (12.8–69.3) NS
MMP-3 (ng/mL)  –  134.9 (21–561) 140.9 (10–345) NS
DAS 28  –  4.02 (1.46–7.33) 3.68 (2.09–5.53) NS 
Data are expressed as means (range).
BMD, bone mineral density; CRP, C-reactive protein; DAS, disease activity score; ESR, erythrocyte sedimentation rate; MMP-3, matrix 
metalloproteinase-3; NS, not significant; OP, postmenopausal osteoporosis; RA, rheumatoid arthritis; RF, rheumatoid factor; VS, vertical 
subluxation. 
P < 0.05 was considered statistically significant among 3 groups. When there was a statistical significance between 2 groups, we showed 
the relationships as follows in the table: *P < 0.05. **P < 0.01. ***P < 0.001.
***
**
*
*
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RESULTS
Demographic data
Ultimately, 99 eligible patients [80 patients with RA 
and 19 with OP (OP group)] agreed to participate in this 
study. Six patients with RA and 6 with OP did not agree 
to participate, and 4 patients with OP withdrew their 
consents. There were 10 patients in the VS group and 70 
in the non-VS group (Table 1). The incidence of VS in 
the present study was 12.5% (10 out of 80 RA subjects) 
and all but 1 patient were asymptomatic (1 patient was 
classified as Ranawat I24).
 Demographic data are shown in Table 1. All subjects 
were postmenopausal, except for 2 in the non-VS group. 
The mean age of the non-VS group was significantly 
lower than in the VS and OP groups, but there were no 
other significant differences between the VS and OP 
groups. 
 Between VS and non-VS groups, there were no sig-
nificant differences in glucocorticoid usage, neurological 
function and severity of RA (Table 1). The duration of 
RA in the VS group was significantly longer than in the 
non-VS group. 
 
Differences in BMD 
BMD(lumbar) in the OP group was significantly lower 
than in the VS and non-VS groups, but there was no 
significant difference between the VS and non-VS 
group (Table 1). There were no statistical differences in 
BMD(hip) among the 3 groups.
 
Morphological findings on coronal reconstructed 
CT images
Left and right levels of LMH(C1) in the VS group were 
significantly lower than in the OP group (Fig. 2). Left 
and right levels of LMH(C2) in the VS group were 
significantly lower than in the non-VS and OP groups; 
however, there was no statistical difference between 
the non-VS and OP groups (Fig. 3). Right FA(C1) in the 
VS group was significantly more acute than in the OP 
group. There were no significant differences in left and 
right FA(C2) levels and odontoid height (Table 2). 
 Compared with the non-VS and OP groups, erosive 
and ankylosing changes in AOJ and AAJ were more 
frequently recognized in the VS group, and larger bone 
defects in the odontoid process were also found in the 
VS group (Table 2). 
 
Three-dimensional analysis using 3D-TBSAS
The average V(C1) in the RA and OP groups was 6.91 
mL (4.33–8.96 ) and 5.68 mL (3.22–8.67), respectively. 
The average V(C2) in the RA and OP groups was 7.69 
mL (4.08–11.96) and 5.91 mL (3.60–8.62), respectively. 
The average V(C1-2) in the RA and OP groups was 14.32 
mL (9.25–21.63) and 12.67 mL (6.81–19.97), respec-
tively. The average vBMD(C1) in the RA and OP groups 
was 809.7 mg/mL (625.4–1067.9) and 755.5 mg/mL 
(639.9–842.6), respectively. The average vBMD(C2) in 
the RA and OP groups was 762.3 mg/mL (639.6–1106.8) 
and 741.7 mg/mL (673.3–840.2), respectively. The aver-
age vBMD(C1-2) in the RA and OP groups was 782.4 
mg/mL (633.6–1086.2) and 740.9 mg/mL (590.1–902.0), 
respectively. Volumes and vBMDs at UCS in the RA 
group were larger than in the OP group, but the differ-
ence was not significant. vBMD(C1) was greater than 
vBMD(C2) in both the RA and OP groups. V(C2) was 
larger than V(C1) in both the RA and OP groups.
 vBMD(C1), vBMD(C2) and vBMD(C1-2) showed a 
positive significant correlation with BMD(lumbar) but 
not BMD(hip) [vBMD(C1) versus BMD(lumbar): r = 
0.580, P < 0.001, vBMD(C2) versus BMD(lumbar): r = 
0.466, P = 0.003, vBMD(C1-2) versus BMD(lumbar): r 
= 0.466, P = 0.001]. vBMDs at the UCS were strongly 
positively correlated with each other [vBMD(C1) versus 
vBMD(C2): r = 0.950, P < 0.001, vBMD(C1) versus 
vBMD(C1-2): r = 0.972, P < 0.001, vBMD(C2) versus 
vBMD(C1-2): r = 0.992, P < 0.001].
 
Fig. 3. Measurements of LMH(C2) in the OP, non-VS and 
VS groups. The VS group shows lower levels of right and left 
LMH(C2). P < 0.05 was considered statistically significant. 
LMH(C2), lateral mass height of the axis; OP, osteoporosis; VS, 
vertical subluxation. [  ], number of subjects.
Fig. 2. Measurements of LMH(C1) in the OP, non-VS and 
VS groups. The VS group shows lower levels of right and left 
LMH(C1) than the OP group. There is no statistical difference be-
tween the VS and non-VS groups. P < 0.05 was considered statis-
tically significant. LMH(C1), lateral mass height of the atlas; OP, 
osteoporosis; VS, vertical subluxation. [  ], number of subjects.
25
Vertical subluxation in RA/osteoporosis
Relationship between the progression of VS and 
other parameters
There were significant positive correlations between the 
R-J value and left and right LMH at C1 and C2. Addi-
tionally, left and right FA(C1) values were positively cor-
related with left and right LMH(C1) values and the R-J 
value (Table 3). 
 V(C1-2) was significantly correlated with the R-J 
value and V(C1) had a tendency to correlate positively 
with the R-J value; however, there was no relationship 
between V(C2) and the R-J value (Table 3). 
 There was no significant correlation between vB-
MDs at the UCS and the R-J value. vBMD(C1) was neg-
atively correlated with left and right FA(C1) [r = −0.468 (P 
= 0.023) and r = −0.600 (P = 0.038), respectively].
 In the present study, there were significant differenc-
es in age, duration of RA and BMD(lumbar). However, 
when we performed multiple regression logistic analysis 
using the above factors as explanatory variables for VS, 
we found that age [odds ratio: 1.089 for 1 SD, 95% confi-
dence interval (CI): 1.004–1.183, P = 0.041] was the only 
factor that contributed to the progression of VS [duration 
Table 2. Morphological findings on coronal reconstructed CT images
 OP group [n = 19] Non-VS group [n = 70] VS group [n = 10] P value
Odontoid height (mm)  31.9  (27.6–35.5) 32.2  (27.1–38.9) 29.7  (27.4–32.0) 0.236
LMH(C1) (mm) L 11.1  (7.5–15.2) 9.4  (6.1–14.5) 7.5 (4.1–10.5) 0.075
  R 10.9  (7.0–13.7) 9.7 (6.4–15.7) 7.1  (3.1–10.4) 0.075
LMH(C2) (mm) L 12.2  (9.8–14.1) 12.6  (9.4–17.0) 9.4  (3.8–13.8) 0.001
  R 12.7  (10.9–15.7) 12.9  (10.6–16.8) 9.8 (8.4–13.0) 0.001
FA(C1) (˚)  L 59.3  (47.8–70.0) 55.6 (35.2–71.4) 49.7 (42.1–58.0) 0.075
  R 63.5 (51.3–76.5) 54.8 (33.6–75.7) 41.7 (8.5–58.5) 0.013
FA(C2) (˚)  L 22.6 (17.2–28.9) 21.1 (11.1–31.3) 21.3 (14.0–29.7) 0.658
  R 24.2 (16.8–31.1) 21.3 (11.6–34.8) 20.8 (9.3–27.0) 0.286
AOJ changes  Normal  L 15 (78.6) 35 (50.0) 1 (10.0)
  R 15 (78.6) 35 (50.0) 1 (10.0)
 Erosive  L 4 (21.4) 30 (42.9) 6 (60.0) L: < 0.001
  R 4 (21.4) 30 (42.9) 4 (40.0) R: < 0.001
 Ankylosing L 0 (0.0) 5 (7.1) 3 (30.0)
  R 0 (0.0) 5 (7.1) 5 (50.0)
AAJ changes  Normal L 17 (89.5) 38 (54.3) 1 (10.0)
  R 16 (64.2) 34 (48.6) 2 (20.0)
 Erosive L 2 (10.5) 27 (38.6) 5 (50.0) L: < 0.001
  R 2 (10.5) 31 (44.3) 3 (30.0) R: < 0.001
 Ankylosing L 0 (0.0) 5 (7.1) 4 (40.0)
  R 1 (5.3) 5 (7.1) 5 (50.0)
Bone defects in the odontoid process
 Spot  9 (47.4) 34 (48.6) 0 (0.0) < 0.001
 Small  5 (26.3) 31 (44.3) 6 (60.0)
 Large  5 (26.3) 5 (7.1) 4 (40.0)
Data of parameters are expressed as means (range) and non-parametrical data are expressed as the number of patients (%).
AAJ, atlantoaxial joint; AOJ, atlanto-occipital joint; CT, computed tomography; FA, facet angle; L, left; LMH, lateral mass height; NS, 
not significant; OP, postmenopausal osteoporosis; R, right; VS, vertical subluxation.
Mann-Whitney’s U test was used to compare between non-VS and VS groups. Pearson’s chi-square test or Fisher’s exact test, when appro-
priate, was employed for comparisons. 
P values were derived by the comparison between non-VS and VS groups.
Table 3. Relationships between the development of VS 
and other parameters
 Correlation 
 coefficient  P value 
R-J value versus LMH(C1)(R) 0.525  < 0.001
 LMH(C1)(L) 0.287  0.013
 LMH(C2)(R) 0.401  0.003
 LMH(C2)(L) 0.414  < 0.001
 FA(C1)(R) 0.473 < 0.001
 FA(C1)(L) 0.320  0.006
 V(C1) 0.499  0.058
 V(C2) –0.036  NS
 V(C1-2) 0.418  0.047
 vBMD(C1) 0.018  NS
 vBMD(C2) 0.045  NS
 vBMD(C1-2) 0.084  NS
FA(C1)(R) versus LMH(C1)(R) 0.276  0.019
FA(C1)(L) versus LMH(C1)(L) 0.167  0.015
FA, facet angle; L, left; LMH, lateral mass height; NS, not signifi-
cant; R, right; R-J, Redlund-Johnell; V, volume; vBMD, volumet-
ric bone mineral density; VS, vertical subluxation. 
Spearman’s rank correlation coefficient was employed for the 
analysis of relationships between the parameters.
Statistical significance was set at P < 0.05.
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of RA, odds ratio: 1.000 for 1 SD, 95% CI: 0.992–1.007, 
P = 0.911; BMD(lumbar), odds ratio: 0.665 for 1 SD, 
95% CI: 0.006–75.23, P = 0.866].
  
 
DISCUSSION
We hypothesized that OP could promote the develop-
ment of VS, because Neva et al.15 proposed BMD(hip) to 
be a risk factor for VS. However, we could not find sta-
tistically significant relationships between BMD(spine, 
hip or both) and the development of VS. To evaluate the 
relationship between OP and VS progression, it is essen-
tial to measure the BMD at the UCS.
 To the best of our knowledge, there have been only 
a few reports on the BMD at the UCS.25, 26 In those 
reports, BMD levels at only subaxial regions were ana-
lyzed using quantitative CT. In the occipitocervical junc-
tion, there are many bony and artificial structures (false 
teeth and implants), which produce halation and make it 
difficult to perform BMD measurements with high pre-
cision and reproducibility. We resolved these issues by 
using 3D-TBSAS. 
 Three-dimensional analysis revealed that RA pa-
tients had almost the same vBMD as OP patients at 
the UCS, even though RA patients were significantly 
younger and had significantly higher BMD(lumbar). 
Moreover, the volumes at the UCS became smaller with 
progression of VS. However, vBMDs at the UCS were 
not significantly correlated with the development of VS. 
These results were not consistent with our hypothesis, 
perhaps for the following reasons. First, there is a pos-
sibility that vBMD at the UCS might become condensed 
with progression of VS. Although we could not discern 
a relationship between the volumes and vBMDs at the 
UCS (data not shown), we found that FA(C1) became 
sharper with progression of VS. Additionally, FA(C1) 
was negatively correlated with vBMD(C1). These find-
ings could support this possibility. Second, there is 
another possibility that a structural specificity at UCS 
might affect vBMDs at the UCS. The ratio of cortical to 
cancellous bone is higher in the UCS than the lumbar 
spine; therefore, the effects of RA itself or generalized 
OP might be smaller. Moreover, instabilities at the UCS 
cause sclerotic changes. These factors might affect the 
measurements of vBMDs.
 Our results indicated that VS could be induced by 
the collapse of the lateral masses in the UCS. Although 
many previous reports3, 6, 9, 27–30 referred to active syno-
vial proliferation at unstable AAJs, these reports did not 
show how the collapse of the lateral masses progressed. 
Some reports21, 28 focused on the AOJ in RA patients 
found that rheumatoid changes (ankylosing and fusion) 
at the AOJ may progress into VS. In general, it has been 
thought that the orientation of the AAJ changes from 
horizontal to nearly vertical with progression of VS.8 
However, the present study showed that the orientation 
of the AAJ did not significantly change even in VS pa-
tients and that FA(C1) became sharper with progression 
of VS. We considered the following: RA patients with 
long symptom duration had more destructive changes at 
the AOJ than those with short symptom duration. If dis-
ease activity in RA patients were generally maintained 
in moderate conditions for long periods, these patients 
had lower LMH(C1), lower LMH(C2) and sharper 
FA(C1) than early-stage RA patients. On the other hand, 
RA patients with high disease activity, such as mutilat-
ing RA patients, tend to develop VS when the lateral 
masses in the UCS collapse rapidly. 
 The risk factors for VS development was age, RA 
symptom duration and BMD(lumbar). However, we 
could not show statistical relationship between OP and 
VS development. There were several limitations in the 
present study. First, the present study was an observa-
tional study. To investigate the etiology of VS and the 
relationship between the progression of VS and OP more 
clearly, a prospective study should be performed. Sec-
ond, 3D-TBSAS could not calculate vBMD at the UCS 
in RA patients with severe rheumatoid changes. Since it 
was able to measure vBMDs at the UCS in early-stage 
RA, we should recruit more candidates with early-stage 
RA and follow them prospectively.
 In conclusions, VS progressed based on the collapse 
of the lateral masses at the UCS. The C1 facet angle be-
came more acute with progression of VS. The VS group 
had rheumatoid changes at the AAJ, AOJ or both, and 
had more bone defects in the odontoid process than the 
non-VS group. Three-dimensional analysis revealed a 
decrease in the volumes at the UCS with the develop-
ment of VS.
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